BREAKING NEWS
Lung Screening Trial Results and Ovarian Cancer Analysis Published
Primary results from the National Lung Screening Trial show a 20 percent reduction in deaths from lung cancer among heavy smokers who were screened with low-dose helical computed tomography (CT) compared with those screened by chest X-ray. The findings, which appeared online in the New England Journal of Medicine, confirm initial findings from the study reported in November 2010 and include the rate of false-positive results. For more information, read the NCI press release.
In a study reported in Nature, The Cancer Genome Atlas (TCGA) Research Network has analyzed the genomic changes found in ovarian tumors from 500 patients, providing the most comprehensive and integrated look at any cancer type to date. TCGA is jointly funded and managed by NCI and the National Human Genome Research Institute. The NCI press release is available online.
NEWS
New Graphic Tobacco Warning Labels Backed by Research
For the first time in more than a quarter century, the look of a pack of cigarettes sold in the United States is changing, thanks to nine new graphic tobacco warning labels released last week by the Food and Drug Administration (FDA).
By the fall of 2012, tobacco companies will be required to cover half of the front and back of cigarette packs and cartons with the warnings, which include images of cancer-ridden lungs, rotting teeth, and an infant surrounded by secondhand smoke. Read more > >
Common Gene Mutation Found in Hairy Cell Leukemia
The V600E mutation in the BRAF gene may occur frequently in the diseaseNew Cancer Vaccine Shows Promise against Tumors in Mice
Viruses with DNA from healthy human tissue triggered an antitumor immune responseResearchers Scrutinize Genetic Variants Linked to Melanoma
Five DNA variants emerge as the most promising markers of susceptibilityBarrett Esophagus May Progress to Cancer Less Often than Thought
Different diagnostic criteria for condition may limit applicability to U.S.
COMMENTARY
A Conversation with Dr. Martha Linet on Cell Phone Use and Cancer Risk
Dr. Linet discusses the forthcoming IARC monograph that classifies exposure to mobile phones as "possibly carcinogenic to humans." Read more > >
IN DEPTH
Imaging Boot Camp for Cancer Researchers
NCI's annual Cancer Research Imaging Camp trains junior researchers in cutting-edge imaging technology
Featured Clinical Trial: Adding Targeted Therapy to Treatment for Esophageal Cancer
Will adding trastuzumab to chemoradiotherapy before surgery reduce recurrences?
UPDATES
FDA Update
- Potential Cardiac Risks Associated with Smoking Cessation Drug
- Diabetes Drug May Increase Risk of Bladder Cancer
Cancer.gov Update
- NCI Launches International Clinical Trials Portal
Notes
- In Memoriam: PDQ Board Member James Nachman
- DCEG Training Program Receives Langmuir Award
- NCAB Meeting Held This Week
- NCI Hosts BSA Meeting June 20
- Telephone Workshop for Cancer Survivors to Focus on Late Effects
- Japanese Translators of the Bulletin Visit NCI
SCIENCE SNAPSHOTS
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
